Hypoproteinemia and anemia in infants with cystic fibrosis  by Fustik, S. et al.
11. Nutrition S97
388 Hypoproteinemia and anemia in infants with cystic ﬁbrosis
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Macedonia
Aims: The association of hypoproteinemia/hypoalbuminemia, edema, and anemia
is well recognized in infants with cystic ﬁbrosis (CF). The aim of the study was to
estimate the prevalence of protein-energy malnutrition (PEM) in infants diagnosed
as having CF in our region and the possible risk factors for its occurrence.
Methods: The records of all children younger than 12 months who entered our
CF center between January 1990 and December 2006 were reviewed. Clinical and
laboratory proﬁles (hemoglobin, red blood cells count, total serum protein, serum
albumin and liver enzyme levels) and genotype data were analyzed in 115 newly
diagnosed infants with CF during the study period.
Results: PEM was manifested in 39 (33%) CF infants, 29 boys and 10 girls, usually
within the ﬁrst 5 months of life and in breast-fed infants. Mean hemoglobin, red
blood cell count, total serum protein and serum albumin values in PEM subgroup
were, respectively: 76.0 g/l, 2.4 mil/mm3, 38.0 g/l and 16.6 g/l. Clinically signiﬁcant
liver involvement was found in 22 (56.4%) patients with PEM. Concerning the
molecular basis of CF in these patients, PEM was always associated with DF508,
G542X, N1303K and other “severe” mutations.
Conclusion: PEM is a common manifestation of CF in infancy. Early infant age,
male gender, breast-feeding, impaired liver function and the presence of severe
CFTR mutations are predisposed factors for the development of PEM. Since PEM
is life-threatening clinical condition, early diagnosis of CF with immediate initia-
tion of pancreatic enzyme supplementation and nutritional rehabilitation, coupled
with aggressive treatment of infections can improve the clinical outcome of CF
complicated with PEM.
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Introduction: Dieticians rely on CF patients’ bowel habit perception to guide
pancreatic enzyme supplementation. We wanted to see whether CF patients have a
normal view of stool formation, colour and frquency, and whether females noticed
a change in stools with menstruation.
Method: Using the Bristol stool and colour chart we surveyed 55 patients (mean age
23 years (range 17−43), mean BMI 21 (15.6−27.8), mean lipase use 8240 iu/kg/day
(1017–29240), 53 pancreatic insufﬁcient, 25 female), to identify stool consistency
and colour, their view of “normal”, and changes during menses (females).
Results: 6 (3 male) used regular laxatives, 4 opened their bowels < once a day,
15 daily, 2 1−2 a day, 1 twice a day, 1 2−3 a day, and 32 2−4 day. For stool
type and consistency see Table. As regards stool volume, 2 passed small amounts
(pebbles), 13 moderate amounts (1−2 sausages), and the remainder large volumes
(3−4 sausages). 15 females (60%) experienced a change in stool frequency during
their menses and 13 (53%) a change in colour.
Conclusions: CF patients have increased bowel frequency compared to normal
adults, despite expert dietetic attention, and their view of stool normality in terms
of consistency and colour may differ from that of the normal adult population. CF
clinicians need to be aware of this in order to optimise advice for these patients.
Stool type Stool colour
Bristol stool type Patient stool (%) Normal? (%) Colour Patient stool (%) Normal? (%)
1 0 0 Black 0 0
2 11 15 Dark Green 2 0
3 64 47 Dark Brown 54 73
4 14 38 Brown 29 24
5 9 0 Mustard 13 3
6 2 0 Khaki Green 0 0
7 0 0 Lime Green 0 0
8 0 0 Yellow 2 0
